Medical conditions treated by GLP-1
Conditions for which GLP-1 medications are FDA-approved or commonly prescribed.
Comprehensive guides
Obesity
ICD-10: E66.942% of US adults — GLP-1s produce 15-22% weight loss
Full guide →
Type 2 Diabetes
ICD-10: E1137M Americans — GLP-1s lower A1c by 1-2%
Full guide →
Prediabetes
ICD-10: R73.0396M Americans — early GLP-1 use may prevent T2D progression
Full guide →
PCOS
ICD-10: E28.2~10% of women — emerging GLP-1 evidence for weight + insulin
Full guide →
Obstructive Sleep Apnea
ICD-10: G47.33Zepbound FDA-approved Dec 2024 for OSA + obesity
Full guide →
Cardiovascular Disease
ICD-10: I25Wegovy FDA-approved March 2024 for CV risk reduction
Full guide →